Opyl Ltd (AU:OPL) — Market Cap & Net Worth
Market Cap & Net Worth: Opyl Ltd (OPL)
Opyl Ltd (AU:OPL) has a market capitalization of $4.82 Million (AU$6.81 Million) as of September 18, 2026. Listed on the AU stock exchange, this Australia-based company holds position #28753 globally and #1539 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Opyl Ltd's stock price AU$0.02 by its total outstanding shares 296081984 (296.08 Million). Also see Opyl Ltd total assets for a full breakdown of the balance sheet.
Opyl Ltd Market Cap History: 2015 to 2025
Opyl Ltd's market capitalization history from 2015 to 2025. Data shows change from $1.89 Billion to $4.82 Million (-45.14% CAGR). Also see Opyl Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Opyl Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Opyl Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Opyl Ltd (OPL) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
10.01x
Opyl Ltd's market cap is 10.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.89 Billion | $63.46K | -$4.48 Million | 29709.31x | N/A |
| 2016 | $230.45 Million | $56.04K | -$6.08 Million | 4112.40x | N/A |
| 2017 | $104.75 Million | $219.45K | -$3.23 Million | 477.31x | N/A |
| 2018 | $41.90 Million | $413.56K | -$3.04 Million | 101.31x | N/A |
| 2019 | $29.33 Million | $927.04K | -$3.10 Million | 31.64x | N/A |
| 2020 | $36.66 Million | $620.78K | -$926.00K | 59.06x | N/A |
| 2021 | $24.09 Million | $767.72K | -$1.14 Million | 31.38x | N/A |
| 2022 | $6.08 Million | $902.41K | -$2.09 Million | 6.73x | N/A |
| 2023 | $5.87 Million | $617.91K | -$1.73 Million | 9.49x | N/A |
| 2024 | $3.98 Million | $397.64K | -$3.13 Million | 10.01x | N/A |
Competitor Companies of OPL by Market Capitalization
Companies near Opyl Ltd in the global market cap rankings as of September 18, 2026. Review Opyl Ltd tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Opyl Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #734 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1907 globally with a market cap of $12.22 Billion USD ( AU$17.27 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2071 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2140 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #734 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $264.90 |
| #1907 | Pro Medicus Ltd | AU:PME | $12.22 Billion | AU$165.31 |
| #2071 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $69.97 |
| #2140 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $58.96 |
Opyl Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Opyl Ltd's market cap moved from $1.89 Billion to $ 4.82 Million, with a yearly change of -45.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | AU$4.82 Million | +21.05% |
| 2024 | AU$3.98 Million | -32.14% |
| 2023 | AU$5.87 Million | -3.45% |
| 2022 | AU$6.08 Million | -74.78% |
| 2021 | AU$24.09 Million | -34.29% |
| 2020 | AU$36.66 Million | +25.00% |
| 2019 | AU$29.33 Million | -30.00% |
| 2018 | AU$41.90 Million | -60.00% |
| 2017 | AU$104.75 Million | -54.55% |
| 2016 | AU$230.45 Million | -87.78% |
| 2015 | AU$1.89 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Opyl Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.82 Million USD |
| MoneyControl | $4.82 Million USD |
| MarketWatch | $4.82 Million USD |
| marketcap.company | $4.82 Million USD |
| Reuters | $4.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Opyl Ltd
Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool strea… Read more